Cargando…

Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match

PURPOSE: The assessment of health-related quality of life (hrQoL) may need to be reconsidered due to important differences between efficacy (the effect of a treatment under experimental study conditions) and effectiveness (the effect of a treatment under real-world conditions). We presume that most...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiedemann, Felicitas, Porzsolt, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012498/
https://www.ncbi.nlm.nih.gov/pubmed/35431592
http://dx.doi.org/10.2147/POR.S350165
_version_ 1784687807337332736
author Wiedemann, Felicitas
Porzsolt, Franz
author_facet Wiedemann, Felicitas
Porzsolt, Franz
author_sort Wiedemann, Felicitas
collection PubMed
description PURPOSE: The assessment of health-related quality of life (hrQoL) may need to be reconsidered due to important differences between efficacy (the effect of a treatment under experimental study conditions) and effectiveness (the effect of a treatment under real-world conditions). We presume that most researchers intend to describe effects under real-world conditions when investigating hrQoL as an endpoint. Unfortunately, most studies are designed to confirm two theories: the efficacy of a new intervention under experimental study conditions and the real-world effectiveness of this intervention on hrQoL under non-experimental study conditions. Conflicting information emerges when the outcomes are supposed to describe effects under real-world conditions, but the assessment generates results obtained under experimental conditions. This paper examines the existing conflict between efficacy and effectiveness in a sample of 100 studies investigating hrQoL. METHODS: We analysed a sample of freely available publications of clinical studies listed in PubMed between April 2015 and August 2016 which assessed quality of life as an outcome. We assessed the following four characteristics that should differ in studies measuring either efficacy or effectiveness: 1) specification of the study as a randomised controlled trial or not, 2) description of the study design as pragmatic or not, 3) classification of the study as an efficacy or an effectiveness study and 4) number of selected inclusion and exclusion criteria. RESULTS: 91% of the studies assessed hrQoL under experimental conditions (in a randomised controlled trial), but not under real-world conditions. The important difference between efficacy and effectiveness was not described in 60% of the studies. Only 6% of studies classified the study as a pragmatic trial. The difference between inclusion and exclusion criteria was not addressed in any of the investigated studies. CONCLUSION: The results of the four criteria confirmed our hypothesis that hrQoL studies are conducted mainly as experimental, but not pragmatic, trials indicating that the meaningfulness of the important difference between efficacy and effectiveness requires further discussion. KEYWORDS: pragmatic trial, experimental study conditions, real-world conditions, efficacy, effectiveness, pragmatic.
format Online
Article
Text
id pubmed-9012498
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-90124982022-04-16 Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match Wiedemann, Felicitas Porzsolt, Franz Pragmat Obs Res Original Research PURPOSE: The assessment of health-related quality of life (hrQoL) may need to be reconsidered due to important differences between efficacy (the effect of a treatment under experimental study conditions) and effectiveness (the effect of a treatment under real-world conditions). We presume that most researchers intend to describe effects under real-world conditions when investigating hrQoL as an endpoint. Unfortunately, most studies are designed to confirm two theories: the efficacy of a new intervention under experimental study conditions and the real-world effectiveness of this intervention on hrQoL under non-experimental study conditions. Conflicting information emerges when the outcomes are supposed to describe effects under real-world conditions, but the assessment generates results obtained under experimental conditions. This paper examines the existing conflict between efficacy and effectiveness in a sample of 100 studies investigating hrQoL. METHODS: We analysed a sample of freely available publications of clinical studies listed in PubMed between April 2015 and August 2016 which assessed quality of life as an outcome. We assessed the following four characteristics that should differ in studies measuring either efficacy or effectiveness: 1) specification of the study as a randomised controlled trial or not, 2) description of the study design as pragmatic or not, 3) classification of the study as an efficacy or an effectiveness study and 4) number of selected inclusion and exclusion criteria. RESULTS: 91% of the studies assessed hrQoL under experimental conditions (in a randomised controlled trial), but not under real-world conditions. The important difference between efficacy and effectiveness was not described in 60% of the studies. Only 6% of studies classified the study as a pragmatic trial. The difference between inclusion and exclusion criteria was not addressed in any of the investigated studies. CONCLUSION: The results of the four criteria confirmed our hypothesis that hrQoL studies are conducted mainly as experimental, but not pragmatic, trials indicating that the meaningfulness of the important difference between efficacy and effectiveness requires further discussion. KEYWORDS: pragmatic trial, experimental study conditions, real-world conditions, efficacy, effectiveness, pragmatic. Dove 2022-04-11 /pmc/articles/PMC9012498/ /pubmed/35431592 http://dx.doi.org/10.2147/POR.S350165 Text en © 2022 Wiedemann and Porzsolt. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wiedemann, Felicitas
Porzsolt, Franz
Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match
title Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match
title_full Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match
title_fullStr Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match
title_full_unstemmed Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match
title_short Measuring Health-Related Quality of Life in Randomised Controlled Trials: Expected and Reported Results Do Not Match
title_sort measuring health-related quality of life in randomised controlled trials: expected and reported results do not match
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012498/
https://www.ncbi.nlm.nih.gov/pubmed/35431592
http://dx.doi.org/10.2147/POR.S350165
work_keys_str_mv AT wiedemannfelicitas measuringhealthrelatedqualityoflifeinrandomisedcontrolledtrialsexpectedandreportedresultsdonotmatch
AT porzsoltfranz measuringhealthrelatedqualityoflifeinrandomisedcontrolledtrialsexpectedandreportedresultsdonotmatch